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Although preventable and treatable, tuberculosis (TB) remains one 
of the top 10 causes of death worldwide, causing more deaths than 
HIV/AIDS.[1] In 2017, an estimated 10.0 million people developed 
TB disease and an estimated 1.8 million deaths were attributed 
to TB.[1] One of the Sustainable Development Goals (SDGs) is to 
end the global TB epidemic.[2] To achieve this aim, the End TB 
Strategy has set targets related to TB mortality, starting with a 
35% reduction in TB deaths by 2020, reaching a 95% reduction 
by 2035. [3] Although the global TB mortality rate is declining, it is 
likely that many countries will fail to reach these targets and end the 
TB epidemic by 2035.[4]
Since the emergence of HIV in South Africa (SA), the burden of 
TB, together with TB mortality, has been influenced by HIV and 
the extent of antiretroviral therapy (ART) provision, and much of 
the reduction in TB-related mortality has been due to increased 
ART provision.[5] However, as TB mortality remains high, further 
investigation and understanding of who is dying of TB are needed 
so that we can channel our energy and resources into areas most 
likely to yield significant gains, enabling us to reach the targets of 
the End TB Strategy.
All deaths in SA are required to be notified to the Department 
of Home Affairs via the death certification process. Death 
certificates are analysed by Statistics South Africa and compiled 
into official annual mortality reports describing the location of 
deaths (province), ages and causes of death. We analysed TB-related 
mortality in SA over the past decade to inform our understanding 
of TB mortality and the development of strategies needed to end the 
TB epidemic by 2035.
Methods
We retrospectively analysed the 10 death reports for SA released by 
Statistics South Africa from 2008 to 2018 on mortality data for the 
period 2006 - 2016. We extracted data focused on TB as the cause 
of death and linked this information to place and age of death. No 
ethical approval for this study was necessary, as only secondary data 
available in the public domain were used.
In SA, all deaths are supposed to be reported to the Department 
of Home Affairs within 72 hours by a medical practitioner on a 
death notification form. In the absence of a medical practitioner, 
traditional leaders can complete the form. Although a new death 
notification form with changes in perinatal death registration was 
introduced in 2009, this would not have affected the classification 
of deaths attributed to TB. Each death notification form details the 
age, sex, district and International Statistical Classification of Diseases 
and Related Health Problems (ICD-10) code. Multidrug-resistant 
tuberculosis (MDR-TB) and extensively drug-resistant tuberculosis 
are included in the deaths attributed to TB.
Results
During the decade 2006 - 2016, TB was the number one cause of 
death in SA (Fig. 1). During this period, the number of deaths due 
to TB plummeted by 62% from 76 881 to 29 399. Additionally, 
the proportion of deaths due to TB more than halved from 13% 
to <6%.
Table 1 shows the decline in TB mortality linked to the total TB 
caseload in SA. The decline in TB-related mortality occurred at a 
steeper rate than the decline in the TB case notification rate, resulting 
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in reported TB deaths as a proportion of TB 
case notifications declining from 25% in 
2006 to 12% in 2016.
In addition to a decline in TB-related 
mortality in SA, the profile of people dying 
from TB has changed, with the proportion 
of males dying from TB increasing from 55% 
to 62% and a corresponding decrease in the 
female proportion (Table 2). From 2006 to 
2016, TB remained the leading cause of death 
in the male population. However, among 
females, in both 2015 and 2016 diabetes 
mellitus and cerebrovascular accidents 
overtook TB as the leading cause of death.
Fig. 2 and Table 3 show the changes in the 
age of death of people dying from TB. The 
number of children aged <15 years dying 
from TB dropped considerably over the 
period 2006 - 2016, and the proportion of 
total reported TB deaths in this age group 
more than halved from 3.4% to 1.5%. Fig. 2 
clearly illustrates the precipitous decline in 
the number of younger adults aged 15 - 49 
dying from TB, with the proportion of total 
reported TB deaths dropping from >70% to 
less than half. The proportion of total deaths 
in the 50 - 64 age group and in people aged 
≥65 has increased for two reasons: (i) there 
has been a decrease in the number of TB 
deaths in people aged <50 years; and (ii) the 
number of TB deaths in those aged ≥50 has 
been relatively static.
The proportion of deaths attributed to TB 
in each province varied. Table 4 shows that 
in all provinces the number and proportion 
of reported TB deaths decreased from 2006 
to 2016. In Free State and KwaZulu-Natal, 
the proportion of reported TB deaths more 
than halved over the decade reviewed. For 
all provinces, TB was the leading cause of 
death during this period, except in 2016 in 
the Western Cape, Gauteng and Limpopo.
In Fig. 3, the decline in TB mortality 
from 2006 to 2016 is plotted with a solid 
line. The dotted line from 2016 to 2035 is 
the projected decline needed to achieve the 
targets of the End TB Strategy from 2020 
to 2035. Given the steady and encouraging 
decline in TB-related mortality over the past 
decade, this figure suggests that it is possible 
for SA to reach the End TB Strategy targets, 
but a sustained and continued decline in 
TB-related mortality is necessary.
Discussion
TB has consistently been the leading cause 
of death in SA over the past two decades. 
From 1997 TB deaths increased, peaking 
in 2006 with 76  881 deaths (13% of total 
mortality). The number of deaths due to TB 
then steadily declined to 29 399 (6% of total 
mortality) in 2016. Reducing TB deaths to 
meet the End TB Strategy mortality target of 
a 95% reduction in TB mortality (from 2015) 
by 2035 is within our reach, but will require 
ongoing focus and effort.
From 1997 to 2006 there was a steady 
rise in reported TB-related mortality that 
can be attributed to migration, high levels 
of patients co-infected with TB and HIV, 
and the increasing burden of drug-resistant 
TB (DR-TB).[6-9] However, for a number 
of possible reasons, TB-related mortality 
started to decline in 2006 (Fig. 3 and Table 1). 
The first of these reasons is the intensified 
ART roll-out for adults, which resulted in 
marked declines in both HIV/AIDS and 
TB mortality after 2006.[10,11] According to 
National Department of Health data, in 
2004 an estimated 47 500 people were on 
ART, compared with >2 million in 2012.[12,13] 
The evolving clinical eligibility criteria for 
TB patients co-infected with HIV increased 
access to ART and probably contributed 
substantially to the declines in TB-related 
mortality in the 15 - 44-year age group. [14] 
Secondly, sustained effort by the TB 
programme has contributed to a decrease 
in the number of people becoming infected 
with TB, improved treatment outcomes, 
and decreased TB-related mortality.[15] In 
SA, 53% of people living with HIV are on 
isoniazid preventive therapy, 39% of the 
total number of people globally started 
on preventive therapy, including 32 104 
children.[1] Thirdly, increased integration 
of TB and HIV services at a primary care 
level together with political attention, 
civil society mobilisation around TB and 
HIV, and the launch of a national HIV/
TB campaign in 2011 have helped reduce 
deaths from TB.[16]
However, there are still some groups of 
people who are at increased risk of TB-related 
mortality. The first group is patients with 
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Fig. 1. Number of reported TB deaths and TB as a proportion of the total mortality in South Africa, 
2006 - 2016. (TB = tuberculosis.)
Table 1. TB case notifications and reported TB deaths in South Africa, 2006 - 2016
Year
TB case 
notifications, N
TB deaths as a proportion  
of TB case notifications, n (%)
2006 303 114 76 881 (25)
2007 315 315 76 662 (24)
2008 388 782 74 780 (19)
2009 403 889 68 918 (17)
2010 400 391 62 738 (16)
2011 389 974 53 919 (14)
2012 349 582 43 992 (13)
2013 328 896 40 373 (12)
2014 318 193 37 719 (12)
2015 291 793 32 922 (11)
2016 236 702 29 399 (12)
TB = tuberculosis.
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DR-TB. Until recently, mortality in patients 
with DR-TB was much higher than in 
patients with drug-susceptible TB.[17,18] In 
2014 and 2015, the mortality rate of patients 
treated for TB was 8.4%, compared with 
23% for patients treated for DR-TB.[19,20] For 
patients with DR-TB, the hope is that the new 
and repurposed drugs and new regimens 
that have recently been introduced in SA will 
continue to reduce mortality as they become 
increasingly accessible.[21] To capitalise on 
these advances, healthcare workers need 
to ensure that treatment algorithms are 
followed carefully and patients are fully 
informed about the importance of treatment 
adherence to ensure treatment success and 
reduce mortality.
A second group of people who are more 
likely to die of TB are pregnant women. 
In 2011, it was estimated that worldwide 
216 500 pregnant women developed TB, with 
the greatest burden in Africa.[22] In 2014, it 
was estimated that TB was responsible for 
480 000 deaths among women of child-
bearing age.[22] In SA, TB was responsible 
for 11% of maternal deaths between 
2014 and 2016, and it is still the most 
common non-pregnancy-related infection 
responsible for maternal mortality.[23] Not 
only do biological changes in pregnancy 
double the risk of pregnant women 
developing TB compared with non-pregnant 
women,[24,25] but maternal TB has serious 
health consequences for both mothers 
and infants, and pregnancy-associated TB 
can be associated with mortality of up to 
40% if untreated.[25] Moreover, the risk of 
maternal mortality increases dramatically 
in women co-infected with TB and HIV,[26] 
and neonates born to these women also 
have vastly increased morbidity and 
mortality.[25,27] Routine screening for TB, and 
immediate commencement of treatment if 
TB is diagnosed, is important at all antenatal 
visits. In addition, all newborns of mothers 
with TB must be screened for TB according 
to national protocols.
Thirdly, men are more likely to die of 
TB than women. A number of studies have 
documented the substantial contribution of 
TB to the gender disparity in adult mortality, 
as TB and HIV preventive, diagnostic and 
treatment programmes have lower coverage 
of men.[28,29] As proportionally more women 
engage with HIV services (women have 
higher HIV diagnosis and ART coverage 
rates,[30] and lower attrition and mortality 
Table 2. Reported TB deaths v. total mortality in men and women, 2006 - 2016
Year Total male deaths, N Male TB deaths, n (%)
Total TB deaths,  
N (% in males)
2006 306 676 41 985 (14) 76 881 (55)
2007 306 234 41 769 (14) 76 662 (54)
2008 302 744 41 034 (13) 74 780 (55)
2009 294 167 38 290 (13) 68 918 (56)
2010 279 682 35 255 (13) 62 738 (56)
2011 263 981 30 807 (12) 53 919 (57)
2012 250 030 27 410 (11) 43 992 (62)
2013 239 188 23 791 (10) 40 373 (59)
2014 236 613 22 545 (10) 37 719 (60)
2015 241 156 20 111 (8) 32 922 (61)
2016 240 001 18 153 (8) 29 399 (62)
TB = tuberculosis.
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Fig. 2. TB as the cause of death by age group (years), 2006 - 2016. (TB = tuberculosis.)
Table 3. Number and proportion of reported TB deaths by age group, 2006 - 2016
Year
Age group (years), n (%)
1 - 14 15 - 49 50 - 64 ≥65
2006 2 641 (3.4) 57 737 (75.1) 11 904 (15.5) 4 600 (6.0)
2007 2 562 (3.3) 57 346 (74.8) 12 171 (15.9) 4 582 (6.0)
2008 2 37  (3.2) 54 795 (73.3) 12 625 (16.9) 4 983 (6.7)
2009 2 068 (3.0) 49 552 (71.9) 12 267 (17.8) 5 031 (7.3)
2010 1 945 (3.1) 44 230 (70.5) 11 795 (18.8) 4 768 (7.6)
2011 1 402 (2.6) 36 719 (68.1) 10 999 (20.4) 4 799 (8.9)
2012 1 100 (2.5) 29 167 (66.3) 9 414 (21.4) 4 311 (9.8)
2013 767 (1.9) 21 640 (53.6) 13 444 (33.3) 4 522 (11.2)
2014 679 (1.8) 19 576 (51.9) 12 938 (34.3) 4 526 (12.0)
2015 494 (1.5) 16 329 (49.6) 11 753 (35.7) 4 346 (13.2)
2016 441 (1.5) 14 406 (49.0) 10 495 (35.7) 4 057 (13.8)
TB = tuberculosis.
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rates after initiating ART),[31] they have lower 
mortality rates from HIV-associated causes, 
including TB. The faster uptake of life-saving 
HIV treatment among women led to more 
rapid declines in HIV-related mortality in 
women than in men.[5,32] The gender disparity 
in TB mortality signals the need to improve 
efforts to target men with preventive, 
diagnostic and curative health services.
Fourthly, the rise of non-communicable 
diseases in SA, particularly diabetes, and 
the interaction of TB with diabetes and 
HIV increase the risk of TB infection and 
the chance of poor treatment outcomes, 
including death. Integrating the control 
programmes for these three diseases could 
help prevent TB among people with HIV 
and diabetes and reduce the mortality and 
morbidity associated with all three diseases.
Study limitations
Limitations of the data are that our 
analyses were based on the mortality and 
cause-of-death reports for SA released by 
Statistics South Africa. Vital registration 
data are used as the basis of these reports, 
the quality of which is affected by late or 
incomplete registrations, and ill-defined or 
misclassified causes of death.[33] Although 
data completeness and accuracy improved 
from 2006 to 2016, and by 2016, 96% of 
the data were complete and 86.8% were 
accurate, many HIV deaths may have been 
misclassified as TB owing to reluctance of 
medical doctors to report HIV on the death 
certificate or because they did not know the 
HIV status of the deceased.[33,34] Furthermore, 
the percentage of deaths classified as due to 
ill-defined causes during the study period 
ranged between 12% and 14%, higher than 
the internationally recommended standard 
of >10%.[35] Continued improvement of 
cause-of-death information will increase our 
understanding of the burden of disease and 
facilitate monitoring progress towards regional, 
national and international targets.[10,34]
A further limitation of the vital registration 
data is that some TB-related deaths may 
not have been reported as such because 
postmortem results were not available at 
the time the death notification form was 
completed. Furthermore, although there are 
new diagnostic tests for TB, these still have 
limited sensitivity.
Conclusions
Reported TB mortality rates in SA have fallen 
substantially in the past decade, and the End 
TB Strategy target of a 95% reduction in 
TB mortality by 2035 is achievable. Besides 
the strategies for groups of people at risk of 
mortality described above, implementation 
of better diagnostics, novel drugs and 
improved treatment regimens is needed, 
together with better means of delivery and 
consistent implementation of all the basic 
components of a robust TB programme. 
However, as we have known for centuries, 
TB is a disease of the poor and we need to 
address the social determinants that are 
sustaining it. ‘The SDGs are interconnected 
and health goals will only be achieved if the 
other SDGs are met too.’[35]
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